Peter Richard Steenland Iii, MD - Medicare Neurosurgery in Asheville, NC

Peter Richard Steenland Iii, MD is a medicare enrolled "Neurological Surgery" physician in Asheville, North Carolina. He went to University Of North Carolina At Chapel Hill School Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Neurosurgery. He is a member of the group practice Mission Health Community Multispecialty Providers Llc and his current practice location is 7 Vanderbilt Park Dr, Carolina Spine And Neurosurgery Center, Asheville, North Carolina. You can reach out to his office (for appointments etc.) via phone at (828) 255-7776.

Peter Richard Steenland Iii is licensed to practice in North Carolina (license number 2013-00901) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1881814770.

Contact Information

Peter Richard Steenland Iii, MD
7 Vanderbilt Park Dr, Carolina Spine And Neurosurgery Center,
Asheville, NC 28803-1700
(828) 255-7776
(828) 274-7855



Physician's Profile

Full NamePeter Richard Steenland Iii
GenderMale
SpecialityNeurosurgery
Experience18 Years
Location7 Vanderbilt Park Dr, Asheville, North Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Peter Richard Steenland Iii attended and graduated from University Of North Carolina At Chapel Hill School Of Medicine in 2006
  NPI Data:
  • NPI Number: 1881814770
  • Provider Enumeration Date: 04/26/2007
  • Last Update Date: 05/11/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 9032353701
  • Enrollment ID: I20130919000072

Medical Identifiers

Medical identifiers for Peter Richard Steenland Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881814770NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207T00000XNeurological Surgery 2013-00901 (North Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Memorial Mission Hospital And Asheville Surgery CeAsheville, NCHospital
Margaret R Pardee Memorial HospitalHendersonville, NCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mission Health Community Multispecialty Providers Llc9537468574577

News Archive

Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds

New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.

‘Risky' view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Hallucinogens may have therapeutic potential against intimate partner violence

Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.

'Super committee' leaders say progress is happening

The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Peter Richard Steenland Iii allows following entities to bill medicare on his behalf.
Entity NameThe Mcdowell Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699772657
PECOS PAC ID: 2264343979
Enrollment ID: O20031107000487

News Archive

Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds

New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.

‘Risky' view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Hallucinogens may have therapeutic potential against intimate partner violence

Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.

'Super committee' leaders say progress is happening

The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.

Read more Medical News

› Verified 4 days ago

Entity NameMission Hospitals Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548532021
PECOS PAC ID: 0648189969
Enrollment ID: O20120316000506

News Archive

Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds

New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.

‘Risky' view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Hallucinogens may have therapeutic potential against intimate partner violence

Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.

'Super committee' leaders say progress is happening

The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.

Read more Medical News

› Verified 4 days ago

Entity NameMission Health Community Multispecialty Providers Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457719130
PECOS PAC ID: 9537468574
Enrollment ID: O20160426001883

News Archive

Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds

New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.

‘Risky' view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Hallucinogens may have therapeutic potential against intimate partner violence

Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.

'Super committee' leaders say progress is happening

The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter Richard Steenland Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Peter Richard Steenland Iii, MD
Po Box 602811,
Charlotte, NC 28260-2811

Ph: (828) 213-1500
Peter Richard Steenland Iii, MD
7 Vanderbilt Park Dr, Carolina Spine And Neurosurgery Center,
Asheville, NC 28803-1700

Ph: (828) 255-7776

News Archive

Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds

New study reveals that FOXO proteins help maintain healthy cells in the cartilage of the joints.

‘Risky' view of thrombolysis in subtherapeutic warfarin patients disputed

A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.

Ocera Therapeutics presents Phase 2 proof-of-concept study results of AST-120 in non-constipating IBS

Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.

Hallucinogens may have therapeutic potential against intimate partner violence

Evidence in a study led by researchers at the University of British Columbia along with University of Alabama at Birmingham School of Public Health Associate Professor Peter S. Hendricks, Ph.D., suggests hallucinogens such as psilocybin or LSD may have therapeutic potential for reducing intimate partner violence, or IPV.

'Super committee' leaders say progress is happening

The super committee might not have a staff director, rules in place, or a room to meet in, but leaders of the powerful budget-slashing panel insisted Wednesday that progress is being made. Co-chairs Sen. Patty Murray and Rep. Jeb Hensarling said in a joint-statement that they're engaged in "serious discussions" on the details.

Read more News

› Verified 4 days ago


Neurological Surgery Doctors in Asheville, NC

Dr. Eric L Rhoton, MD
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-247-7855
Dr. Jon M Silver, MD
Neurological Surgery
Medicare: Medicare Enrolled
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855
Dr. Richard A Lytle, MD
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855
Dr. Steven M Stranges, MD
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855
Dr. Wesley C Fowler Iii, MD
Neurological Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855
Dr. Ralph C Loomis, MD
Neurological Surgery
Medicare: Medicare Enrolled
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855
Dr. Lary A Schulhof, MD
Neurological Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803
Phone: 828-255-7776    Fax: 828-274-7855

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.